Safety and efficacy of rituximab for relapse prevention in myelin oligodendrocyte glycoprotein immunoglobulin G (MOG-IgG)-associated disorders (MOGAD): A systematic review and meta-analysis
Gaurav Nepal, Sanjeev Kharel, Megan Ariel Coghlan, Parash Rayamajhi, Rajeev Ojha
Topics & Concepts
RituximabMedicineNeuromyelitis opticaMultiple sclerosisTransverse myelitisMyelin oligodendrocyte glycoproteinOptic neuritisAdverse effectInternal medicinePediatricsImmunologyLymphomaExperimental autoimmune encephalomyelitisMultiple Sclerosis Research StudiesPeripheral Neuropathies and DisordersAutoimmune Neurological Disorders and Treatments